Oncolytics Biotech Announces Publication on Pelareorep's Immune Response in Liver Cancer

Filing content

Oncolytics Biotech announced that data published in the Proceedings of the National Academy of Sciences demonstrates pelareorep's ability to transform the tumor microenvironment in liver cancer into an immunologically active state.